Randy Werneth is a seasoned executive with 25 years of experience in both small entrepreneurial and Fortune 500 corporations in the medical device industry.
Mr. Werneth is CEO of Maxwell Biomedical, Inc. developing the next generation of wireless remote cardiac pacing and monitoring implantable device. Mr. Werneth is partner at Evolve Medtech Partners, a technology development company. Previously, Mr. Werneth successfully started several other venture backed companies including Acutus Medical, Securus Medical, Ablation Frontiers, and CryoTherapeutics. Mr. Werneth previously held senior level positions at Medtronic, Micro Therapeutics, and Edwards Lifesciences where he engineered and/or managed the design and development of numerous medical technologies and clinical procedures in the fields of stents, neuro-embolic materials, vulnerable plaque, and electrophysiology. He also sits on the board of several venture funded medical device companies in the US and Europe. Mr. Werneth holds a B.S. degree in Engineering from Arizona State University (ASU) and a Masters in Science from University of California at Los Angeles (UCLA). He has more than 70 issued U.S. Patents in various medical technology fields.
